Data / Form D filings / Alcyone Therapeutics, Inc.
Alcyone Therapeutics, Inc.: Form D filings
Alcyone Therapeutics, Inc., a health care company in Lowell, MA, filed 11 Form D notices with the SEC between 2012 and 2025. The latest, on January 8, 2025, reports $19 million sold of a $31.6 million offering to 25 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 116 John Street, Suite 300, Lowell, MA, 01852
- Phone
- (781) 929-6094
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1544927
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | Amendment | $31,608,219 | $19,032,812 | $12,575,407 | 25 | Nov 7, 2023 | sec.gov |
| Nov 22, 2023 | New notice | $31,608,219 | $17,257,814 | $14,350,405 | 22 | Nov 7, 2023 | sec.gov |
| Jun 17, 2021 | New notice | $37,103,349 | $37,103,349 | 31 | Jun 8, 2021 | sec.gov | |
| Sep 2, 2020 | New notice | $19,458,809 | $17,550,174 | $1,908,635 | 28 | Aug 21, 2020 | sec.gov |
| Jul 3, 2019 | New notice | $3,000,000 | $2,208,330 | $791,670 | 17 | Jun 21, 2019 | sec.gov |
| Apr 11, 2019 | New notice | $1,650,000 | $1,650,000 | 17 | Mar 28, 2019 | sec.gov | |
| Jan 17, 2018 | New notice | $5,140,609 | $5,140,609 | 22 | Jan 8, 2018 | sec.gov | |
| Dec 24, 2015 | New notice | $3,720,388 | $3,640,319 | $80,069 | 20 | Dec 14, 2015 | sec.gov |
| Jan 13, 2014 | New notice | $4,000,000 | $4,000,000 | 19 | Dec 31, 2013 | sec.gov | |
| May 20, 2013 | New notice | $1,000,004 | $1,000,004 | 18 | May 9, 2013 | sec.gov | |
| Mar 27, 2012 | New notice | $2,000,000 | $1,835,007 | $164,993 | 14 | Dec 29, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edgar D. Jannotta | Director | |
| David Donabedian | Director | |
| Norbert D. Riedel | Director | |
| Stephen D. Oesterle | Director | |
| PJ Anand | Executive Officer, Director | |
| Richard Upton | Director | |
| Cameron Durrant | Director |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
Every Form D from the week of Jan 6, 2025 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Alcyone Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.